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background: Nonischemic cardiomyopathy (NICM) patients represent a growing population referred for catheter ablation. However, the scar 
patterns and electrical footprint of NICM are heterogenous, with reported ablation outcomes that are inferior to patients with postinfarct scar. 
Smaller scars and fewer late potentials intrinsic to the substrate may limit ablation targets.
methods: Patients referred for VT ablation were analyzed into three groups based on electroanatomic mapping findings: Type I) confluent scar with 
late potentials Type II) confluent scar without LP Type III) minimal/no scar or LP detected. Baseline and procedural characteristics were analyzed and 
correlated with freedom from recurrent VT at 1 year.
results: Amongst 70 patients undergoing 90 procedures (1/04-10/12), 59 patients had complete follow-up at 1 year. No differences were seen 
in baseline characteristics between the three groups (Type I=44, II=10, III=5) with regard to age, antiarrhythmics, or EF (9±13 vs 28±12 vs 30±11, 
p=0.97). At 12 months, the freedom from VT was 48% in Type I, 30% in Type II, and 0% in Type III. (SEE FIGURE 1)
conclusions: Significant heterogeneity is present within the NICM population referred for VT ablation, ranging from substrates with confluent scar 
and LPs, akin to ICM, to undetectable scar. A three-tiered prognostication schema may be helpful in identifying patients at the time of ablation (Type 
III) that may require adjunctive neuraxial modulation.
 
